PHARMACY

Kaleo donates 50,000 naloxone auto-injectors

BY David Salazar

RICHMOND, Va. — Kaléo this week made a commitment to fighting opioid addiction. The company has pledged to donate 50,000 of its Evzio (naloxone) auto-injectors ahead of the UNITE to Face Addiction rally, which will take place on Oct. 4 on the National Mall in Washington, D.C. The company will donate the auto-injectors to local public health departments that it finds to have the greatest need.

"In the midst of a public health emergency surrounding addiction it is time for all of us to have improved resources,” said Greg Williams, co-founder of Facing Addiction, group organizing Sunday’s rally. “We are proud to be part of what we believe to be the largest donation of naloxone in history. It is time for all of us to collectively face addiction and this donation from kaléo will help save so many lives.”

The public health departments that receive the emergency overdose treatement will be determined based on research from the U.S. Dept. of Health and Human Services. HHS secretary Sylvia Burwell said the department is happy to work with the company on its kaléo Cares program, as it makes the only naloxone injector for caregivers and consumers.

“This unprecedented donation is designed to help make Evzio vailable to those without traditional insurance coverage who are being served by local public health departments determined to be in greatest need,” kaléo president and CEO Spencer Williamson said. “Since the launch of the kaléo Cares Product Donation Program last October, donated Evzio have contributed to more than 135 reported lives saved. We believe this latest donation will help save hundreds of people in the months ahead.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

SPJ founder, publisher Gary Cohen passes away

BY David Salazar

ALEXANDRIA, Va. — Gary M. Cohen, founder and publisher of Specialty Pharma Journal,  has passed away, the publication announced Friday. Cohen founded the publication in 2010 and served as publisher until his unexpected death on Sept. 18. 

“It is with great sadness that we mourn the passing of Gary M. Cohen,” SPJ editor Nicole Watkins, Editor, Specialty Pharma Journal. “SPJ, and the pharmacy community as a whole, has lost an iconic leader and visionary. Cohen was a master of his craft. His passion and dedication to the Specialty Pharmacy industry was second to none, and his contributions will live on.”

Cohen had more than 30 years’ experience working in pharmacy- and specialty pharmacy-related organizations. He founded and served as CEO of pharmaceutical education and marketing company Pharmacy Power-Pak and was president of CEO of Synergy Healthcare Communications. Cohen also founded and served as CEO of the National Association of Specialty Pharmacy, and was the founder and executive director of the Specialty Pharmacy Certification Board (SPCB).

“We are saddened by the sudden passing of Gary Cohen,” SPCB president Ray Tancredi said. “Gary was a tireless proponent of specialty pharmacy education and certification. The Specialty Pharmacy Certification Board offers our condolences to Gary's family."

“Gary will be dearly missed. His energy and confidence in those around him was uplifting and encouraging. He had an ability to make every interaction meaningful,” Watkins said. “While Gary was a great leader and teacher, he was an even better friend. Our heart and prayers go out to his family and friends.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Bayer names longtime vet president of U.S. pharmaceuticals division

BY David Salazar

WHIPPANY, N.J. — Bayer HealthCare Pharmaceuticals’ U.S. division has a new president. The company announced Thursday that longtime Bayer veteran Habib Dable would be taking over as president its U.S. pharmaceutical business, reporting to Philip Blake, who is the head of region Americas for Bayer HealthCare Pharmaceuticals and heads up U.S. corporate functions for the company.

“Habib Dable is a highly respected leader at Bayer, and I'm thrilled to have someone with such a wealth of experience step in to lead the company's largest pharmaceuticals market worldwide,” Blake said. “Having spent more than two decades at Bayer in a range of key roles with increasing management responsibility, Habib will be a critical asset as we look to build on our positive momentum in the U.S. to create long-term growth.”

Dable began his career at Bayer in 1994 as a sales representative, a position from which he moved to several senior roles in Japan, Canada and the U.S. where he led global product launches, among other responsibilities. Since 2013, Dable had been Bayer HealthCare Pharmaceuticals’ global head of specialty medicine, where he oversaw oncology, ophthalmology, neurology and hematology. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?